Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,431 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05651724Recruiting
MASH screening study for people with diabetes or obesity
This study screens participants for MASH (a type of liver fat inflammation) using information about your health and risk factors. It may help you and your care team learn whether you could have MASH and need follow-up.
Brussels, Vlaams-brabantAges 18–75 - NCT06485895Recruiting
Testing a new TB blood test for diagnosis
This study is testing a new blood test (IGRA) to see if it can help doctors diagnose active and latent (hidden) tuberculosis. If you are already being treated for TB and have had an IGRA blood test, you may be able to join.
MarseilleAges 18 years+ - NCT06536010Recruiting
Testing a new combination therapy for AML
This trial tests a new combination therapy called VAG for people with acute myeloid leukemia (AML) who haven't been treated before. The goal is to see if it works better than standard treatments.
Huai'an, JiangsuAges 18–75 - NCT07786220Recruiting
How thinking and memory affect inhaler use in COPD
This study looks at whether memory and thinking skills affect how well people with COPD use their inhalers. It may help find ways to improve inhaler technique and make treatment more effective.
Timișoara, Timiș CountyAges 18–100 - NCT06534762RecruitingPhase 2
Miraberon for advanced solid tumors (first treatment)
This study tests a drug called Miraberon for people with advanced solid tumors that have not yet been treated with chemotherapy or other cancer drugs. The goal is to see if Miraberon can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–65 - NCT06536179Recruiting
New research on mesothelioma: using surgery tissue samples
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
Naples, CampaniaAges Any age - NCT07788118RecruitingPhase 1/Phase 2
A new car-t therapy for relapsed large b-cell lymphoma
This trial tests a new type of CAR-T cell therapy that may be better at remembering and attacking lymphoma cells. It is for people with large B-cell lymphoma that has not responded to standard treatments or has come back.
Hangzhou, ZhejiangAges 18–75 - NCT07789210RecruitingPhase 2
Neoadjuvant targeted therapy for BRAF-mutant colorectal cancer
This trial is testing a combination of two targeted drugs (encorafenib and cetuximab) with standard chemotherapy before surgery in people with a specific type of colorectal cancer that has the BRAF V600E mutation and is locally advanced or has limited spread. The goal is to see if this treatment can shrink tumors and improve outcomes.
Hangzhou, ZhejiangAges 18–75 - NCT07791966Recruiting
Brain stimulation for chronic pain
This study tests a non-invasive brain stimulation technique to help people with chronic pain, specifically Complex Regional Pain Syndrome (CRPS), manage pain-related avoidance behaviors. It may help reduce pain and improve daily function.
Cleveland, OhioAges 18 years+ - NCT07789119Recruiting
Biospecimen and data collection for bladder and urinary tract cancer
This study collects samples like blood, urine, or tissue, along with medical information, from people with bladder or urinary tract cancer. The samples are used for research to better understand the disease and may lead to new treatments.
Houston, TexasAges 18 years+ - NCT07790107Enrolling by invitation
Pre-appointment messaging for behavioral health intake
This trial is testing a way to send pre-appointment messages to adults who are starting outpatient behavioral health therapy at Geisinger. It aims to see if these messages help improve attendance and engagement in treatment.
Danville, PennsylvaniaAges 18 years+ - NCT07788196RecruitingPhase 2
Adding anti-HER2 therapy after surgery for early-stage gastric cancer
This trial tests whether adding a targeted therapy (anti-HER2) to standard chemotherapy after surgery can improve outcomes for people with early-stage gastric cancer that has high HER2 levels. It aims to see if the combination is more effective than chemotherapy alone.
Xi'an, ShaanxiAges 18 years+ - NCT07790445RecruitingPhase 4
Adjuvant chemotherapy for bile duct cancer after surgery
This study tests whether giving chemotherapy directly into the liver (HAIC) plus an oral chemo pill (capecitabine) after surgery helps prevent bile duct cancer from coming back, compared to just the pill. It's for people who recently had their cancer completely removed.
Zhengzhou, HenanAges 18 years+ - NCT07791355Recruiting
Testing pain reprocessing therapy for chronic pain
This study tests a psychological treatment called Pain Reprocessing Therapy (PRT) for people with chronic primary pain like fibromyalgia or back pain. It aims to see if this treatment is feasible and helpful in a specialist pain clinic.
StockholmAges 18 years+ - NCT07784309Enrolling by invitationPhase 1
Cell therapy for CD7-positive blood cancer
This study tests a new cell therapy for people with certain types of blood cancer that have returned or not responded to standard treatments. The therapy uses immune cells modified to target a marker called CD7 on cancer cells. It may help reduce or eliminate the cancer.
TianjinAges 3–70 - NCT07785804Enrolling by invitation
Testing a smartphone app for preventing and treating low back pain in nurses
This study tests a smartphone app called SelfBack to see if it helps prevent and manage low back pain in nurses. If you join, you'll use the app and answer questionnaires online over some time.
Brussels, Brussels CapitalAges 18–18 - NCT07787975Enrolling by invitation
Understanding genetic test results with RNA sequencing
This study uses a special test called RNA sequencing to find genetic causes of diseases when standard genetic tests didn't give answers. It might help you get a clearer diagnosis or find out if a genetic change actually causes your condition.
San Francisco, CaliforniaAges 2 years+ - NCT06537115RecruitingPhase 4
Vitamin D, protein, and exercise for muscle loss
This trial tests whether a combination of a vitamin D-like drug (idecalcitol), whey protein powder, and a structured exercise program can help rebuild muscle strength and mass in people with sarcopenia. It lasts about 6 months.
Hangzhou, ZhejiangAges 30 years+ - NCT07790237Recruiting
Daily supplement for reducing facial wrinkles and improving skin radiance
This study tests whether a daily oral supplement called Dermial® can reduce signs of skin aging and make skin look more radiant. If you're a woman aged 35-65 with visible wrinkles and you're happy to keep your usual skincare routine for about 3 months, you might be a good fit.
Madrid, MadridAges 35–65 - NCT07791745RecruitingPhase 2/Phase 3
Comparing treatments for advanced head and neck cancer
This trial tests a new combination of treatments for head and neck cancer that has returned or spread and can't be cured with local therapy. It compares a standard chemotherapy with or without an additional drug to see which is more effective and safe.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07789639RecruitingPhase 4
Sunscreen effectiveness study on back skin
This study tests two sunscreen products to see how well they protect the skin from sun damage. Participants will have a small area on their back treated and then exposed to a controlled amount of UV light to measure the products' effectiveness.
Winston-Salem, North CarolinaAges 18–75 - NCT07790770RecruitingPhase 1
A study of a new drug in healthy adults
This study tests a new drug called CMS-F021 in healthy volunteers. It aims to see how the drug behaves in the body after single and multiple doses.
BeijingAges 18–55 - NCT07791797RecruitingPhase 4
Comparing absorption of two supplement formulas in healthy adults
This trial compares how well your body absorbs two different supplement formulas. It may help researchers understand which formula is better for healthy adults.
Fortitude Valley, QueenslandAges 18 years+ - NCT06543108Recruiting
Comparing two PET scans for stomach cancer
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
Changsha, HunanAges 18–90
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,431 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.